Grants and Contributions:
Title:
Pharmacokinetic profile of Nerinetide (NA-1) and Plasmin Resistant PSD-95 Inhibitors in cynomolgus macaques.
Agreement Number:
925290
Agreement Value:
$515,620.00
Agreement Date:
Dec 1, 2018 - Aug 31, 2020
Description:
This proposal focuses on translating academic discoveries into new treatments for stroke recovery and chronic neurological diseases that constitute massive socioeconomic burdens in Canada and worldwide. It provides a foundation for a biotechnology industry in Ontario to address these issues and build wealth in our province.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Toronto, Ontario, CA M5V 1E7
Reference Number:
172-2018-2019-Q4-925290
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
861256576
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 62 days.
Amendment Date
Jul 2, 2020
Recipient's Legal Name:
NoNO Inc.
Federal Riding Name:
Spadina--Fort York
Federal Riding Number:
35101
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: